No, do not use Bactrim and doxycycline together for a buttock abscess
For a buttock abscess, incision and drainage (I&D) is the primary treatment, and if antibiotics are indicated, use EITHER Bactrim OR doxycycline as monotherapy—not both together. There is no evidence supporting combination therapy with these two agents for simple skin abscesses, and using both simultaneously exposes patients to unnecessary adverse effects without additional benefit 1, 2.
Treatment Algorithm for Buttock Abscess
Step 1: Perform Incision and Drainage
- I&D is the cornerstone of treatment for all cutaneous abscesses 1, 2
- For simple abscesses in immunocompetent patients, I&D alone may be sufficient with cure rates of 85-90% 2
Step 2: Determine if Antibiotics Are Needed
Add antibiotics ONLY if any of the following are present 2:
- Multiple abscesses or rapidly progressive infection
- Systemic signs of infection (fever >38°C, tachycardia, tachypnea, abnormal WBC)
- Significant surrounding cellulitis (>5 cm of erythema)
- Immunosuppression or significant comorbidities (diabetes, HIV/AIDS)
- Extremes of age
- Failed I&D alone
- Difficult to drain location (though buttock is typically drainable)
Step 3: Choose ONE Oral Antibiotic (Not Both)
If antibiotics are indicated, select ONE of the following for MRSA coverage 1:
First-line options:
- Trimethoprim-sulfamethoxazole (Bactrim): 1-2 double-strength tablets twice daily for 5-10 days 1
- Doxycycline: 100 mg twice daily for 5-10 days 1
- Clindamycin: 300-450 mg four times daily (if local resistance <10%) 1
Why Not Combine Them?
There is no evidence supporting dual therapy with Bactrim plus doxycycline for skin abscesses:
No synergy demonstrated: Unlike the combination of trimethoprim-sulfamethoxazole (which itself is already a combination drug targeting sequential steps in folate synthesis), adding doxycycline provides no additional sequential blockade or synergistic effect 3
Both are bacteriostatic: Doxycycline and TMP-SMX are both bacteriostatic agents with similar mechanisms (protein synthesis inhibition vs. folate synthesis inhibition) 1. Combining two bacteriostatic agents doesn't enhance killing
Increased adverse effects: Combining these agents doubles the risk of side effects without proven benefit. Bactrim carries risks of hyperkalemia, hyponatremia, bone marrow suppression, and hypersensitivity reactions 3. Adding doxycycline increases GI upset, photosensitivity, and other tetracycline-related effects
Guidelines recommend monotherapy: IDSA guidelines consistently recommend single-agent therapy for purulent SSTIs when antibiotics are used 1, 2
Evidence Quality Considerations
The 2014 IDSA guidelines 1 are the highest quality evidence here, representing expert consensus from the premier infectious disease society. These guidelines explicitly list TMP-SMX, doxycycline, and clindamycin as alternative options (not additive ones) for MRSA coverage in skin infections.
Research evidence shows that even TMP-SMX alone after I&D may not significantly reduce treatment failure compared to placebo (though it may reduce new lesion formation) 4, 5. A 2007 randomized trial found no significant difference in clinical failure rates between TMP-SMX and doxycycline monotherapy 6.
Common Pitfalls to Avoid
- Over-prescribing antibiotics: Many simple abscesses after adequate I&D don't need antibiotics at all 2, 7
- Using combination therapy without indication: This is antibiotic stewardship violation 7
- Forgetting to culture: Send abscess drainage for culture and susceptibility testing to guide therapy if the patient fails initial treatment 1
- Inadequate drainage: The most common cause of treatment failure is incomplete I&D, not antibiotic choice 2
If the patient fails monotherapy with one agent, consider switching to an alternative oral agent (not adding a second one), or escalating to IV therapy with vancomycin, daptomycin, or linezolid if severe 1, 2.